Plunkett Research Online: Cognetivity Neurosciences

COGNETIVITY NEUROSCIENCES (CGN:CNQ) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cognetivity Neurosciences Ltd is developing a platform technology comprising of a visual stimulus based diagnostic test and artificial intelligence tools to support the early detection and monitoring of cognitive impairment in neurodegenerative diseases, with initial emphasis on dementia in Alzheime.....



Cognetivity Neurosciences
Ticker: CGN
Exchange: CNQ
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 604 688-9588
Fax: 778 329-9361
Address: 1075 West Georgia Street
Suite 1980
Vancouver, BC V6E 3C9 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Medical Laboratories
ContactsDescription

Cognetivity Neurosciences Ltd is developing a platform technology comprising of a visual stimulus based diagnostic test and artificial intelligence tools to support the early detection and monitoring of cognitive impairment in neurodegenerative diseases, with initial emphasis on dementia in Alzheime.....See More See More

Auditor:
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: